Cargando…
Association Between Preterm-Birth Phenotypes and Differential Morbidity, Growth, and Neurodevelopment at Age 2 Years: Results From the INTERBIO-21st Newborn Study
IMPORTANCE: The etiologic complexities of preterm birth remain inadequately understood, which may impede the development of better preventative and treatment measures. OBJECTIVE: To examine the association between specific preterm-birth phenotypes and clinical, growth, and neurodevelopmental differe...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922239/ https://www.ncbi.nlm.nih.gov/pubmed/33646288 http://dx.doi.org/10.1001/jamapediatrics.2020.6087 |
_version_ | 1783658643293470720 |
---|---|
author | Villar, Jose Restrepo-Méndez, María C. McGready, Rose Barros, Fernando C. Victora, Cesar G. Munim, Shama Papageorghiou, Aris T. Ochieng, Roseline Craik, Rachel Barsosio, Hellen C. Berkley, James A. Carvalho, Maria Fernandes, Michelle Cheikh Ismail, Leila Lambert, Ann Norris, Shane A. Ohuma, Eric O. Stein, Alan Tshivuila-Matala, Chrystelle O. O. Zondervan, Krina T. Winsey, Adele Nosten, Francois Uauy, Ricardo Bhutta, Zulfiqar A. Kennedy, Stephen H. |
author_facet | Villar, Jose Restrepo-Méndez, María C. McGready, Rose Barros, Fernando C. Victora, Cesar G. Munim, Shama Papageorghiou, Aris T. Ochieng, Roseline Craik, Rachel Barsosio, Hellen C. Berkley, James A. Carvalho, Maria Fernandes, Michelle Cheikh Ismail, Leila Lambert, Ann Norris, Shane A. Ohuma, Eric O. Stein, Alan Tshivuila-Matala, Chrystelle O. O. Zondervan, Krina T. Winsey, Adele Nosten, Francois Uauy, Ricardo Bhutta, Zulfiqar A. Kennedy, Stephen H. |
author_sort | Villar, Jose |
collection | PubMed |
description | IMPORTANCE: The etiologic complexities of preterm birth remain inadequately understood, which may impede the development of better preventative and treatment measures. OBJECTIVE: To examine the association between specific preterm-birth phenotypes and clinical, growth, and neurodevelopmental differences among preterm newborns compared with term newborns up to age 2 years. DESIGN, SETTING, AND PARTICIPANTS: The INTERBIO-21st study included a cohort of preterm and term newborn singletons enrolled between March 2012 and June 2018 from maternity hospitals in 6 countries worldwide who were followed up from birth to age 2 years. All pregnancies were dated by ultrasonography. Data were analyzed from November 2019 to October 2020. EXPOSURES/INTERVENTIONS: Preterm-birth phenotypes. MAIN OUTCOMES AND MEASURES: Infant size, health, nutrition, and World Health Organization motor development milestones assessed at ages 1 and 2 years; neurodevelopment evaluated at age 2 years using the INTERGROWTH-21st Neurodevelopment Assessment (INTER-NDA) tool. RESULTS: A total of 6529 infants (3312 boys [50.7%]) were included in the analysis. Of those, 1381 were preterm births (mean [SD] gestational age at birth, 34.4 [0.1] weeks; 5148 were term births (mean [SD] gestational age at birth, 39.4 [0] weeks). Among 1381 preterm newborns, 8 phenotypes were identified: no main maternal, fetal, or placental condition detected (485 infants [35.1%]); infections (289 infants [20.9%]); preeclampsia (162 infants [11.7%]); fetal distress (131 infants [9.5%]); intrauterine growth restriction (110 infants [8.0%]); severe maternal disease (85 infants [6.2%]); bleeding (71 infants [5.1%]); and congenital anomaly (48 infants [3.5%]). For all phenotypes, a previous preterm birth was a risk factor for recurrence. Each phenotype displayed differences in neonatal morbidity and infant outcomes. For example, infants with the no main condition detected phenotype had low neonatal morbidity but increased morbidity and hospitalization incidence at age 1 year (odds ratio [OR], 2.2; 95% CI, 1.8-2.7). Compared with term newborns, the highest risk of scoring lower than the 10th centile of INTER-NDA normative values was observed in the fine motor development domain among newborns with the fetal distress (OR, 10.6; 95% CI, 5.1-22.2) phenotype. CONCLUSIONS AND RELEVANCE: Results of this study suggest that phenotypic classification may provide a better understanding of the etiologic factors and mechanisms associated with preterm birth than continuing to consider it an exclusively time-based entity. |
format | Online Article Text |
id | pubmed-7922239 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Medical Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-79222392021-03-19 Association Between Preterm-Birth Phenotypes and Differential Morbidity, Growth, and Neurodevelopment at Age 2 Years: Results From the INTERBIO-21st Newborn Study Villar, Jose Restrepo-Méndez, María C. McGready, Rose Barros, Fernando C. Victora, Cesar G. Munim, Shama Papageorghiou, Aris T. Ochieng, Roseline Craik, Rachel Barsosio, Hellen C. Berkley, James A. Carvalho, Maria Fernandes, Michelle Cheikh Ismail, Leila Lambert, Ann Norris, Shane A. Ohuma, Eric O. Stein, Alan Tshivuila-Matala, Chrystelle O. O. Zondervan, Krina T. Winsey, Adele Nosten, Francois Uauy, Ricardo Bhutta, Zulfiqar A. Kennedy, Stephen H. JAMA Pediatr Original Investigation IMPORTANCE: The etiologic complexities of preterm birth remain inadequately understood, which may impede the development of better preventative and treatment measures. OBJECTIVE: To examine the association between specific preterm-birth phenotypes and clinical, growth, and neurodevelopmental differences among preterm newborns compared with term newborns up to age 2 years. DESIGN, SETTING, AND PARTICIPANTS: The INTERBIO-21st study included a cohort of preterm and term newborn singletons enrolled between March 2012 and June 2018 from maternity hospitals in 6 countries worldwide who were followed up from birth to age 2 years. All pregnancies were dated by ultrasonography. Data were analyzed from November 2019 to October 2020. EXPOSURES/INTERVENTIONS: Preterm-birth phenotypes. MAIN OUTCOMES AND MEASURES: Infant size, health, nutrition, and World Health Organization motor development milestones assessed at ages 1 and 2 years; neurodevelopment evaluated at age 2 years using the INTERGROWTH-21st Neurodevelopment Assessment (INTER-NDA) tool. RESULTS: A total of 6529 infants (3312 boys [50.7%]) were included in the analysis. Of those, 1381 were preterm births (mean [SD] gestational age at birth, 34.4 [0.1] weeks; 5148 were term births (mean [SD] gestational age at birth, 39.4 [0] weeks). Among 1381 preterm newborns, 8 phenotypes were identified: no main maternal, fetal, or placental condition detected (485 infants [35.1%]); infections (289 infants [20.9%]); preeclampsia (162 infants [11.7%]); fetal distress (131 infants [9.5%]); intrauterine growth restriction (110 infants [8.0%]); severe maternal disease (85 infants [6.2%]); bleeding (71 infants [5.1%]); and congenital anomaly (48 infants [3.5%]). For all phenotypes, a previous preterm birth was a risk factor for recurrence. Each phenotype displayed differences in neonatal morbidity and infant outcomes. For example, infants with the no main condition detected phenotype had low neonatal morbidity but increased morbidity and hospitalization incidence at age 1 year (odds ratio [OR], 2.2; 95% CI, 1.8-2.7). Compared with term newborns, the highest risk of scoring lower than the 10th centile of INTER-NDA normative values was observed in the fine motor development domain among newborns with the fetal distress (OR, 10.6; 95% CI, 5.1-22.2) phenotype. CONCLUSIONS AND RELEVANCE: Results of this study suggest that phenotypic classification may provide a better understanding of the etiologic factors and mechanisms associated with preterm birth than continuing to consider it an exclusively time-based entity. American Medical Association 2021-03-01 2021-05 /pmc/articles/PMC7922239/ /pubmed/33646288 http://dx.doi.org/10.1001/jamapediatrics.2020.6087 Text en Copyright 2021 Villar J et al. JAMA Pediatrics. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License. |
spellingShingle | Original Investigation Villar, Jose Restrepo-Méndez, María C. McGready, Rose Barros, Fernando C. Victora, Cesar G. Munim, Shama Papageorghiou, Aris T. Ochieng, Roseline Craik, Rachel Barsosio, Hellen C. Berkley, James A. Carvalho, Maria Fernandes, Michelle Cheikh Ismail, Leila Lambert, Ann Norris, Shane A. Ohuma, Eric O. Stein, Alan Tshivuila-Matala, Chrystelle O. O. Zondervan, Krina T. Winsey, Adele Nosten, Francois Uauy, Ricardo Bhutta, Zulfiqar A. Kennedy, Stephen H. Association Between Preterm-Birth Phenotypes and Differential Morbidity, Growth, and Neurodevelopment at Age 2 Years: Results From the INTERBIO-21st Newborn Study |
title | Association Between Preterm-Birth Phenotypes and Differential Morbidity, Growth, and Neurodevelopment at Age 2 Years: Results From the INTERBIO-21st Newborn Study |
title_full | Association Between Preterm-Birth Phenotypes and Differential Morbidity, Growth, and Neurodevelopment at Age 2 Years: Results From the INTERBIO-21st Newborn Study |
title_fullStr | Association Between Preterm-Birth Phenotypes and Differential Morbidity, Growth, and Neurodevelopment at Age 2 Years: Results From the INTERBIO-21st Newborn Study |
title_full_unstemmed | Association Between Preterm-Birth Phenotypes and Differential Morbidity, Growth, and Neurodevelopment at Age 2 Years: Results From the INTERBIO-21st Newborn Study |
title_short | Association Between Preterm-Birth Phenotypes and Differential Morbidity, Growth, and Neurodevelopment at Age 2 Years: Results From the INTERBIO-21st Newborn Study |
title_sort | association between preterm-birth phenotypes and differential morbidity, growth, and neurodevelopment at age 2 years: results from the interbio-21st newborn study |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922239/ https://www.ncbi.nlm.nih.gov/pubmed/33646288 http://dx.doi.org/10.1001/jamapediatrics.2020.6087 |
work_keys_str_mv | AT villarjose associationbetweenpretermbirthphenotypesanddifferentialmorbiditygrowthandneurodevelopmentatage2yearsresultsfromtheinterbio21stnewbornstudy AT restrepomendezmariac associationbetweenpretermbirthphenotypesanddifferentialmorbiditygrowthandneurodevelopmentatage2yearsresultsfromtheinterbio21stnewbornstudy AT mcgreadyrose associationbetweenpretermbirthphenotypesanddifferentialmorbiditygrowthandneurodevelopmentatage2yearsresultsfromtheinterbio21stnewbornstudy AT barrosfernandoc associationbetweenpretermbirthphenotypesanddifferentialmorbiditygrowthandneurodevelopmentatage2yearsresultsfromtheinterbio21stnewbornstudy AT victoracesarg associationbetweenpretermbirthphenotypesanddifferentialmorbiditygrowthandneurodevelopmentatage2yearsresultsfromtheinterbio21stnewbornstudy AT munimshama associationbetweenpretermbirthphenotypesanddifferentialmorbiditygrowthandneurodevelopmentatage2yearsresultsfromtheinterbio21stnewbornstudy AT papageorghiouarist associationbetweenpretermbirthphenotypesanddifferentialmorbiditygrowthandneurodevelopmentatage2yearsresultsfromtheinterbio21stnewbornstudy AT ochiengroseline associationbetweenpretermbirthphenotypesanddifferentialmorbiditygrowthandneurodevelopmentatage2yearsresultsfromtheinterbio21stnewbornstudy AT craikrachel associationbetweenpretermbirthphenotypesanddifferentialmorbiditygrowthandneurodevelopmentatage2yearsresultsfromtheinterbio21stnewbornstudy AT barsosiohellenc associationbetweenpretermbirthphenotypesanddifferentialmorbiditygrowthandneurodevelopmentatage2yearsresultsfromtheinterbio21stnewbornstudy AT berkleyjamesa associationbetweenpretermbirthphenotypesanddifferentialmorbiditygrowthandneurodevelopmentatage2yearsresultsfromtheinterbio21stnewbornstudy AT carvalhomaria associationbetweenpretermbirthphenotypesanddifferentialmorbiditygrowthandneurodevelopmentatage2yearsresultsfromtheinterbio21stnewbornstudy AT fernandesmichelle associationbetweenpretermbirthphenotypesanddifferentialmorbiditygrowthandneurodevelopmentatage2yearsresultsfromtheinterbio21stnewbornstudy AT cheikhismailleila associationbetweenpretermbirthphenotypesanddifferentialmorbiditygrowthandneurodevelopmentatage2yearsresultsfromtheinterbio21stnewbornstudy AT lambertann associationbetweenpretermbirthphenotypesanddifferentialmorbiditygrowthandneurodevelopmentatage2yearsresultsfromtheinterbio21stnewbornstudy AT norrisshanea associationbetweenpretermbirthphenotypesanddifferentialmorbiditygrowthandneurodevelopmentatage2yearsresultsfromtheinterbio21stnewbornstudy AT ohumaerico associationbetweenpretermbirthphenotypesanddifferentialmorbiditygrowthandneurodevelopmentatage2yearsresultsfromtheinterbio21stnewbornstudy AT steinalan associationbetweenpretermbirthphenotypesanddifferentialmorbiditygrowthandneurodevelopmentatage2yearsresultsfromtheinterbio21stnewbornstudy AT tshivuilamatalachrystelleoo associationbetweenpretermbirthphenotypesanddifferentialmorbiditygrowthandneurodevelopmentatage2yearsresultsfromtheinterbio21stnewbornstudy AT zondervankrinat associationbetweenpretermbirthphenotypesanddifferentialmorbiditygrowthandneurodevelopmentatage2yearsresultsfromtheinterbio21stnewbornstudy AT winseyadele associationbetweenpretermbirthphenotypesanddifferentialmorbiditygrowthandneurodevelopmentatage2yearsresultsfromtheinterbio21stnewbornstudy AT nostenfrancois associationbetweenpretermbirthphenotypesanddifferentialmorbiditygrowthandneurodevelopmentatage2yearsresultsfromtheinterbio21stnewbornstudy AT uauyricardo associationbetweenpretermbirthphenotypesanddifferentialmorbiditygrowthandneurodevelopmentatage2yearsresultsfromtheinterbio21stnewbornstudy AT bhuttazulfiqara associationbetweenpretermbirthphenotypesanddifferentialmorbiditygrowthandneurodevelopmentatage2yearsresultsfromtheinterbio21stnewbornstudy AT kennedystephenh associationbetweenpretermbirthphenotypesanddifferentialmorbiditygrowthandneurodevelopmentatage2yearsresultsfromtheinterbio21stnewbornstudy |